Nothing Special   »   [go: up one dir, main page]

PL337503A1 - Vaccines containing f1ge polypeptide from helicobacter pylori - Google Patents

Vaccines containing f1ge polypeptide from helicobacter pylori

Info

Publication number
PL337503A1
PL337503A1 PL98337503A PL33750398A PL337503A1 PL 337503 A1 PL337503 A1 PL 337503A1 PL 98337503 A PL98337503 A PL 98337503A PL 33750398 A PL33750398 A PL 33750398A PL 337503 A1 PL337503 A1 PL 337503A1
Authority
PL
Poland
Prior art keywords
f1ge
polypeptide
helicobacter pylori
vaccines containing
vaccines
Prior art date
Application number
PL98337503A
Other languages
English (en)
Inventor
Thomas Berglindh
Bjoern Mellgard
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL337503A1 publication Critical patent/PL337503A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL98337503A 1997-06-12 1998-06-08 Vaccines containing f1ge polypeptide from helicobacter pylori PL337503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (1)

Publication Number Publication Date
PL337503A1 true PL337503A1 (en) 2000-08-28

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337503A PL337503A1 (en) 1997-06-12 1998-06-08 Vaccines containing f1ge polypeptide from helicobacter pylori

Country Status (21)

Country Link
EP (1) EP1009764A1 (xx)
JP (1) JP2002507118A (xx)
KR (1) KR20010013699A (xx)
CN (1) CN1259960A (xx)
AR (1) AR012896A1 (xx)
AU (1) AU8048798A (xx)
BR (1) BR9810026A (xx)
CA (1) CA2293293A1 (xx)
EE (1) EE9900566A (xx)
HU (1) HUP0003164A3 (xx)
ID (1) ID23052A (xx)
IL (1) IL133144A0 (xx)
IS (1) IS5288A (xx)
NO (1) NO996132L (xx)
NZ (1) NZ501427A (xx)
PL (1) PL337503A1 (xx)
SE (1) SE9702242D0 (xx)
SK (1) SK173099A3 (xx)
TR (1) TR199903060T2 (xx)
WO (1) WO1998056816A1 (xx)
ZA (1) ZA984696B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
NO996132L (no) 2000-01-28
BR9810026A (pt) 2000-09-19
JP2002507118A (ja) 2002-03-05
NO996132D0 (no) 1999-12-10
WO1998056816A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
AU8048798A (en) 1998-12-30
CA2293293A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
CN1259960A (zh) 2000-07-12
ID23052A (id) 2000-01-20
HUP0003164A2 (hu) 2000-12-28
ZA984696B (en) 1999-01-04
HUP0003164A3 (en) 2001-10-29
TR199903060T2 (xx) 2000-09-21
EE9900566A (xx) 2000-06-15
SE9702242D0 (sv) 1997-06-12
SK173099A3 (en) 2000-06-12
AR012896A1 (es) 2000-11-22
KR20010013699A (ko) 2001-02-26
NZ501427A (en) 2000-09-29
IL133144A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
AU8005098A (en) Alpha1,3-fucosyltransferase of helicobacter pylori
GB2325623B (en) Fluoxetine enteric pellets
DE69330515D1 (en) Test auf helicobacter pylori
IL122340A0 (en) Helicobacter pylori antigens and vaccine compositions
AU3630093A (en) Helicobacter pylori proteins useful for vaccines and diagnostics
HUP0002139A3 (en) Chimeric flavivirus vaccines
IL123775A0 (en) Adhesin from helicobacter pylori
EP0821698A4 (en) PROTECTIVE HELIOBACTER ANTIGENES
AU2126495A (en) Recombinase-deficient (helicobacter pylori) and related methods
AU5160596A (en) Helicobacter pylori cagi region
AU1698699A (en) (helicobacter pylori) vaccine formulations
PL337503A1 (en) Vaccines containing f1ge polypeptide from helicobacter pylori
IL118021A0 (en) Modified polypeptides for enhanced immunogenicity
EP0770092A4 (en) NICKEL-BINDING PROTEIN FROM -i (HELICOBACTER PYLORI)
AU7137896A (en) Helicobacter pylori protein
AU5871598A (en) (h. pylori) antigens
IL122561A0 (en) Adherence gene from helicobacter pylori and polypeptide coded thereby
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
GB9413050D0 (en) Helicobacter pylori carbonic anhydrase-like protein
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
ZA98588B (en) H. Pylori antigens.
AU4789400A (en) (helicobacter pylori) antigens
IL116541A0 (en) Helicobacter proteins and vaccines
ZA955499B (en) Helicobacter proteins and vaccines